88 related articles for article (PubMed ID: 15695960)
1. Placebo controlled trial of methotrexate in systemic sclerosis.
Das SN; Alam MR; Islam N; Rahman MH; Sutradhar SR; Rahman S; Khan GK; Rahim A; Haq SA
Mymensingh Med J; 2005 Jan; 14(1):71-4. PubMed ID: 15695960
[TBL] [Abstract][Full Text] [Related]
2. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.
van den Hoogen FH; Boerbooms AM; Swaak AJ; Rasker JJ; van Lier HJ; van de Putte LB
Br J Rheumatol; 1996 Apr; 35(4):364-72. PubMed ID: 8624641
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.
Zulian F; Martini G; Vallongo C; Vittadello F; Falcini F; Patrizi A; Alessio M; La Torre F; Podda RA; Gerloni V; Cutrone M; Belloni-Fortina A; Paradisi M; Martino S; Perilongo G
Arthritis Rheum; 2011 Jul; 63(7):1998-2006. PubMed ID: 21305525
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of subcutaneous versus oral methotrexate in active rheumatoid arthritis.
Islam MS; Haq SA; Islam MN; Azad AK; Islam MA; Barua R; Hasan MM; Mahmood M; Safiuddin M; Rahman MM; Osmany MF; Bari N; Rumki RS; Rashid FB
Mymensingh Med J; 2013 Jul; 22(3):483-8. PubMed ID: 23982537
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.
Gonzalez-Lopez L; Garcia-Gonzalez A; Vazquez-Del-Mercado M; Muñoz-Valle JF; Gamez-Nava JI
J Rheumatol; 2004 Aug; 31(8):1568-74. PubMed ID: 15290737
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial.
Hara M; Ishiguro N; Katayama K; Kondo M; Sumida T; Mimori T; Soen S; Nagai K; Yamaguchi T; Yamamoto K;
Mod Rheumatol; 2014 May; 24(3):410-8. PubMed ID: 24252050
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis.
Furst DE; Venkatraman MM; McGann M; Manohar PR; Booth-LaForce C; Sarin R; Sekar PG; Raveendran KG; Mahapatra A; Gopinath J; Kumar PR
J Clin Rheumatol; 2011 Jun; 17(4):185-92. PubMed ID: 21617554
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
10. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
11. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate in rheumatoid arthritis: a 2 year experience at a university hospital in Pakistan.
Ali AA; Iqbal MP; Hussain MA; Mehboobali N; Beg JA; Rahbar MH
J Pak Med Assoc; 1998 Jan; 48(1):3-6. PubMed ID: 9610077
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial.
Rigby W; Tony HP; Oelke K; Combe B; Laster A; von Muhlen CA; Fisheleva E; Martin C; Travers H; Dummer W
Arthritis Rheum; 2012 Feb; 64(2):350-9. PubMed ID: 21905001
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
[TBL] [Abstract][Full Text] [Related]
16. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma.
Johnson SR; Feldman BM; Pope JE; Tomlinson GA
J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled, comparative study of human anti-TNF antibody adalimumab in combination with methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis.
Chen DY; Chou SJ; Hsieh TY; Chen YH; Chen HH; Hsieh CW; Lan JL
J Formos Med Assoc; 2009 Apr; 108(4):310-9. PubMed ID: 19369178
[TBL] [Abstract][Full Text] [Related]
19. Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.
Guyot P; Taylor PC; Christensen R; Pericleous L; Drost P; Eijgelshoven I; Bergman G; Lebmeier M
J Rheumatol; 2012 Jun; 39(6):1198-206. PubMed ID: 22505698
[TBL] [Abstract][Full Text] [Related]
20. MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.
Vergunst CE; Gerlag DM; von Moltke L; Karol M; Wyant T; Chi X; Matzkin E; Leach T; Tak PP
Arthritis Rheum; 2009 Dec; 60(12):3572-81. PubMed ID: 19950299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
